Anti-hip fracture efficacy of biophosphonates: a Bayesian analysis of clinical trials.
about
Bisphosphonates can prevent recurrent hip fracture and reduce the mortality in osteoporotic patient with hip fracture: A meta-analysisThe osteoporotic fracture prevention program in rural areas (OFRA): a protocol for a cluster-randomized health care fund driven intervention in a routine health care settingMechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy.Management of severe osteoporosis.The impact of preventive measures on the burden of femoral fractures - a modelling approach to estimating the impact of fall prevention exercises and oral bisphosphonate treatment for the years 2014 and 2025Shifting the focus in fracture prevention from osteoporosis to fallsPharmaco-epistemology for the prescribing geriatrician.Expression analysis of matrix metalloproteinase-9 in epithelialized and nonepithelialized apical periodontitis lesions.Prevention of osteoporosis-related fractures among postmenopausal women and older men.Effect of bisphosphonate initiation at week 2 versus week 12 on short-term functional recovery after femoral neck fracture: a randomized controlled trial.Pharmacogenetics of osteoporosis-related bone fractures: moving towards the harmonization and validation of polymorphism diagnostic tools.Use of bisphosphonates in the management of postmenopausal osteoporosis.Genetic profiling and individualized assessment of fracture risk.Vibration Therapy to Prevent Bone Loss and Falls: Mechanisms and Efficacy.Genetic profiling and individualized prognosis of fracture.Secular trends in major osteoporotic fractures among 50+ adults in Denmark between 1995 and 2010
P2860
Q26749442-1BA7EB14-8BEE-431E-9D49-A2D0EF2747EBQ28596159-0D7A9B73-1AA3-41DB-B6CB-BFF770ED4A75Q34009569-AA0B6367-36FB-4EC0-8008-1B444104F357Q35852252-66718029-8211-44DC-AC0F-301DC40F2943Q35977780-C5235201-09AF-49D0-952D-28E807ADDCA9Q36392180-BC157905-3A43-4483-8746-02C8EF402562Q37247261-A02F86B8-A319-4A2B-B1FD-86AD5F098C91Q37342733-405FCFB0-9129-49D9-9516-E7D674EB3710Q37428448-7BF50D16-2C75-46B3-BFA9-0B029D7EFBDBQ37693875-0E531CB5-C268-4ADE-A564-E0809757A913Q37791155-6AC2E37B-4064-4B4E-8241-C619C5ED75C6Q37800181-7542434E-16AE-408C-A523-C5D5AD906E9DQ38079132-09BF3290-4A86-418C-9234-482C4D50D2BEQ38604526-7357F7B5-72BB-4F07-8F88-EB9C52A07AAEQ45402394-3D41AC8C-B302-4F7A-A01B-A07180F7287AQ58700333-7D252D54-7BCD-410F-9053-899A98362D71
P2860
Anti-hip fracture efficacy of biophosphonates: a Bayesian analysis of clinical trials.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Anti-hip fracture efficacy of biophosphonates: a Bayesian analysis of clinical trials.
@ast
Anti-hip fracture efficacy of biophosphonates: a Bayesian analysis of clinical trials.
@en
type
label
Anti-hip fracture efficacy of biophosphonates: a Bayesian analysis of clinical trials.
@ast
Anti-hip fracture efficacy of biophosphonates: a Bayesian analysis of clinical trials.
@en
prefLabel
Anti-hip fracture efficacy of biophosphonates: a Bayesian analysis of clinical trials.
@ast
Anti-hip fracture efficacy of biophosphonates: a Bayesian analysis of clinical trials.
@en
P2093
P2860
P356
P1476
Anti-hip fracture efficacy of biophosphonates: a Bayesian analysis of clinical trials.
@en
P2093
John A Eisman
Nguyen D Nguyen
Tuan V Nguyen
P2860
P304
P356
10.1359/JBMR.050903
P577
2006-02-01T00:00:00Z